Orphan Drug Manufacturers To Discuss Easier Drug Access To Rare Disease Patients Globally, 9-11 April 2013, Washington DC

Date: Jan-14-2013Though making headway in developed orphan drug markets such as US, Europe, Australia and some countries in Asia, rare disease patients in the rest of the world have yet to see the light of day.

Over 400 biotechs, pharma, research institutions and regulators will gather at the World Orphan Drug Congress USA in Washington DC on April 9-11, 2013. Key speakers include Flemming Ornskov, Shire's Chief Executive Designate; Charles Johnson, Vice President, Respiratory Medicine from Vertex Pharmaceuticals; Jimmy Lin, Founder & President of the Rare Genomics Institute; and, Martine Zimmerman, Executive Director, Global Regulatory Affairs from Alexion Pharmaceuticals.

This conference and expo provides a platform for key movers and shakers of the orphan drug industry to come together and discover partnerships and collaborations to expedite orphan drugs to patients globally.

Various facets to highlight key needs of the industry are as follows:
Pitch & Partner session for biotechs and research institutions looking for investors and partners
Technical On-floor Seminar for orphan drug manufacturers and developers looking for better technologies, equipment and processes
Exhibition showcase floor for technology and solution providers who have stellar offerings in the orphan drug space
2-day strategic conference for key decision makers from bigger biotech, pharma, regulators, globally

Participants will learn:
How to access developing orphan drug markets globally
How to expedite orphan drugs to rare disease patients
How to identify partners in faster orphan drug development
How to adapt to evolving orphan drug environments in developed US & European markets
How to launch an orphan drug successfully

To register or learn more visit http://www.terrapinn.com/orphandrug

CONTACT:

Caroline Hornby,

Marketing Director
 Terrapinn


caroline.hornby (at) terrapinn.com


+1 646 619 1792

Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.